popular Painkiller Ibuprofen Linked to Reduced Cancer Risk in New Study
Berlin – A new study observing over 42,000 women aged 55 to 74 suggests a potential link between regular ibuprofen use and a reduced risk of certain cancers. Researchers found that women who took at least 30 ibuprofen tablets per month experienced a 25 percent lower risk of developing uterine cancer compared to those who took fewer than four tablets monthly. The protective effect appeared strongest in women with pre-existing heart disease.
The 12-month observational study, detailed recently, builds on growing evidence suggesting ibuprofen’s potential beyond pain relief. previous research indicates the non-steroidal anti-inflammatory drug (NSAID) may also lower the risk of colon, breast, lung, and prostate cancers. Studies have shown ibuprofen can inhibit the growth of colon cancer and potentially prevent its recurrence, and may offer a protective effect against lung cancer even in smokers.
However, experts caution against self-medication with ibuprofen for cancer prevention. While the findings are promising, NSAIDs like ibuprofen carry potential side effects, including stomach ulcers, kidney damage, and heart problems.
Researchers emphasize the need for further large-scale studies to confirm ibuprofen’s anti-cancer effects and determine appropriate preventative applications, particularly for individuals in high-risk groups. If confirmed, ibuprofen could become a significant tool in long-term cancer prevention strategies.
